DRUG FOR INHIBITING ADIPOSE CELL DIFFERENTIATION AND INSULIN RESISTANCE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20180015148A1
SERIAL NO

15524094

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides use of endostatin or a functional variant thereof in the preparation of a medicament for treating dietary obesity, non-alcoholic fatty liver disease, insulin resistance or glucose intolerance. In the embodiments of the present invention, the functional variant may be YH-16, mES, mYH-16, m003, m007, mZ101, or the like.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TSINGHUA UNIVERSITY100084 TSINGHUA UNIVERSITY BEIJING HAIDIAN DISTRICT BEIJING CITY BEIJING CITY 100084
BEIJING PROTGEN LTDROOM B412 NO 5 KAITUO ROAD HAIDIAN DISTRICT BEIJING 100085

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
FU, Yan Beijing, CN 93 971
LI, Hui Beijing, CN 1266 14805
LU, Xinan Beijing, CN 8 8
LUO, Yongzhang Beijing, CN 28 56
WANG, Hui Beijing, CN 1012 7908
ZHAN, Shunli Beijing, CN 3 1
ZHOU, Daifu Beijing, CN 4 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation